ProAssurance Nears Merger Completion with The Doctors Company
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
An announcement from ProAssurance ( (PRA) ) is now available.
ProAssurance said its stockholders approved on June 24, 2025, the previously announced merger under which Jackson Acquisition Corporation, a wholly owned subsidiary of The Doctors Company, will merge into ProAssurance, leaving ProAssurance as a wholly owned subsidiary of The Doctors Company. The U.S. Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period on July 2, 2025, clearing a key antitrust step for the deal.
The Doctors Company has now obtained all necessary approvals from insurance regulators in the states where ProAssurance’s insurance subsidiaries are domiciled, as of June 23, 2026. With all required regulatory consents secured, the companies expect to close the merger on June 26, 2026, subject only to remaining customary closing conditions, marking a significant milestone toward consolidating their insurance operations under a single owner.
The most recent analyst rating on (PRA) stock is a Hold
with a $25.00 price target.
To see the full list of analyst forecasts on ProAssurance stock,
see the PRA Stock Forecast page.
Spark’s Take on PRA Stock
According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.
The score is mainly constrained by weak cash-flow conversion and top-line/premium contraction signals despite an earnings rebound and a manageable balance sheet. Technicals are modestly supportive, but a high P/E without a dividend meaningfully reduces the valuation score.
To see Spark’s full report on PRA stock,
click here.
More about ProAssurance
ProAssurance Corporation is a Delaware-based insurance company operating through multiple insurance subsidiaries, with a focus on specialized lines that are subject to regulation in multiple U.S. jurisdictions. The company’s operations are overseen by various state insurance regulators, reflecting its role in regulated insurance markets and its need for extensive regulatory approvals for major corporate transactions.
Average Trading Volume: 922,653
Technical Sentiment Signal: Hold
Current Market Cap: $1.27B
See more insights into PRA stock on TipRanks’ Stock Analysis page.
